Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1045 | 2885 | 42.2 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
147 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES | 23275 |
1045 | 1 | LIPOSOMES//IMMUNOLIPOSOMES//LONG CIRCULATING LIPOSOMES | 2885 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LIPOSOMES | authKW | 829502 | 31% | 9% | 907 |
2 | IMMUNOLIPOSOMES | authKW | 479225 | 4% | 41% | 111 |
3 | LONG CIRCULATING LIPOSOMES | authKW | 271218 | 2% | 57% | 45 |
4 | PEGYLATED LIPOSOMES | authKW | 221171 | 2% | 37% | 56 |
5 | ACCELERATED BLOOD CLEARANCE ABC PHENOMENON | authKW | 192403 | 1% | 91% | 20 |
6 | SUB BIOPHARMACEUT SCI | address | 188300 | 1% | 57% | 31 |
7 | JOURNAL OF LIPOSOME RESEARCH | journal | 155766 | 3% | 16% | 93 |
8 | REMOTE LOADING | authKW | 151165 | 1% | 71% | 20 |
9 | ACCELERATED BLOOD CLEARANCE | authKW | 142578 | 1% | 84% | 16 |
10 | PHARMACOKINET BIOPHARMACEUT | address | 139168 | 2% | 26% | 50 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 14690 | 42% | 0% | 1215 |
2 | Biophysics | 4824 | 16% | 0% | 449 |
3 | Biochemistry & Molecular Biology | 2225 | 26% | 0% | 754 |
4 | Oncology | 2031 | 15% | 0% | 446 |
5 | Chemistry, Multidisciplinary | 869 | 14% | 0% | 402 |
6 | Chemistry, Medicinal | 844 | 6% | 0% | 167 |
7 | Materials Science, Biomaterials | 340 | 2% | 0% | 59 |
8 | Nanoscience & Nanotechnology | 157 | 4% | 0% | 101 |
9 | Medicine, Research & Experimental | 147 | 4% | 0% | 112 |
10 | Biochemical Research Methods | 134 | 3% | 0% | 94 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SUB BIOPHARMACEUT SCI | 188300 | 1% | 57% | 31 |
2 | PHARMACOKINET BIOPHARMACEUT | 139168 | 2% | 26% | 50 |
3 | ADV THER EUT | 120884 | 1% | 29% | 40 |
4 | MOL TARGETING POLYMER TOXICOL GRP | 69950 | 1% | 37% | 18 |
5 | NANOMED EDUC | 66243 | 0% | 52% | 12 |
6 | SECT LIPOSOME | 44091 | 0% | 83% | 5 |
7 | PHARMACOKINET PHARMACEUT | 42329 | 0% | 100% | 4 |
8 | PHARMACEUT NANOTECHNOL NANOTOXICOL | 39661 | 1% | 25% | 15 |
9 | CAROLINA CANC NANOTECHNOL EXCELLENCE | 36053 | 1% | 23% | 15 |
10 | ANIM STUDIES CORE | 31747 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF LIPOSOME RESEARCH | 155766 | 3% | 16% | 93 |
2 | JOURNAL OF CONTROLLED RELEASE | 18041 | 4% | 2% | 113 |
3 | BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 15841 | 3% | 2% | 97 |
4 | JOURNAL OF DRUG TARGETING | 14961 | 2% | 3% | 47 |
5 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 14460 | 5% | 1% | 148 |
6 | ADVANCED DRUG DELIVERY REVIEWS | 11895 | 2% | 2% | 55 |
7 | BIOCHIMICA ET BIOPHYSICA ACTA | 11758 | 6% | 1% | 180 |
8 | CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 8280 | 1% | 5% | 16 |
9 | PHARMACEUTICAL RESEARCH | 5323 | 2% | 1% | 64 |
10 | SELECTIVE CANCER THERAPEUTICS | 4328 | 0% | 8% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPOSOMES | 829502 | 31% | 9% | 907 | Search LIPOSOMES | Search LIPOSOMES |
2 | IMMUNOLIPOSOMES | 479225 | 4% | 41% | 111 | Search IMMUNOLIPOSOMES | Search IMMUNOLIPOSOMES |
3 | LONG CIRCULATING LIPOSOMES | 271218 | 2% | 57% | 45 | Search LONG+CIRCULATING+LIPOSOMES | Search LONG+CIRCULATING+LIPOSOMES |
4 | PEGYLATED LIPOSOMES | 221171 | 2% | 37% | 56 | Search PEGYLATED+LIPOSOMES | Search PEGYLATED+LIPOSOMES |
5 | ACCELERATED BLOOD CLEARANCE ABC PHENOMENON | 192403 | 1% | 91% | 20 | Search ACCELERATED+BLOOD+CLEARANCE+ABC+PHENOMENON | Search ACCELERATED+BLOOD+CLEARANCE+ABC+PHENOMENON |
6 | REMOTE LOADING | 151165 | 1% | 71% | 20 | Search REMOTE+LOADING | Search REMOTE+LOADING |
7 | ACCELERATED BLOOD CLEARANCE | 142578 | 1% | 84% | 16 | Search ACCELERATED+BLOOD+CLEARANCE | Search ACCELERATED+BLOOD+CLEARANCE |
8 | ANTI PEG IGM | 129630 | 0% | 88% | 14 | Search ANTI+PEG+IGM | Search ANTI+PEG+IGM |
9 | STEALTH LIPOSOMES | 97569 | 1% | 33% | 28 | Search STEALTH+LIPOSOMES | Search STEALTH+LIPOSOMES |
10 | PEG LIPOSOMES | 76438 | 1% | 43% | 17 | Search PEG+LIPOSOMES | Search PEG+LIPOSOMES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DRUMMOND, DC , MEYER, O , HONG, KL , KIRPOTIN, DB , PAPAHADJOPOULOS, D , (1999) OPTIMIZING LIPOSOMES FOR DELIVERY OF CHEMOTHERAPEUTIC AGENTS TO SOLID TUMORS.PHARMACOLOGICAL REVIEWS. VOL. 51. ISSUE 4. P. 691 -743 | 180 | 56% | 783 |
2 | ALLEN, TM , CULLIS, PR , (2013) LIPOSOMAL DRUG DELIVERY SYSTEMS: FROM CONCEPT TO CLINICAL APPLICATIONS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 65. ISSUE 1. P. 36 -48 | 95 | 41% | 735 |
3 | MOGHIMI, SM , HUNTER, AC , MURRAY, JC , (2001) LONG-CIRCULATING AND TARGET-SPECIFIC NANOPARTICLES: THEORY TO PRACTICE.PHARMACOLOGICAL REVIEWS. VOL. 53. ISSUE 2. P. 283 -318 | 114 | 36% | 1941 |
4 | SAWANT, RR , TORCHILIN, VP , (2012) CHALLENGES IN DEVELOPMENT OF TARGETED LIPOSOMAL THERAPEUTICS.AAPS JOURNAL. VOL. 14. ISSUE 2. P. 303-315 | 89 | 67% | 62 |
5 | BARENHOLZ, Y , (2012) DOXIL (R) - THE FIRST FDA-APPROVED NANO-DRUG: LESSONS LEARNED.JOURNAL OF CONTROLLED RELEASE. VOL. 160. ISSUE 2. P. 117 -134 | 50 | 57% | 567 |
6 | TORCHILIN, V , (2008) ANTIBODY-MODIFIED LIPOSOMES FOR CANCER CHEMOTHERAPY.EXPERT OPINION ON DRUG DELIVERY. VOL. 5. ISSUE 9. P. 1003-1025 | 130 | 51% | 68 |
7 | YINGCHONCHAROEN, P , KALINOWSKI, DS , RICHARDSON, DR , (2016) LIPID-BASED DRUG DELIVERY SYSTEMS IN CANCER THERAPY: WHAT IS AVAILABLE AND WHAT IS YET TO COME.PHARMACOLOGICAL REVIEWS. VOL. 68. ISSUE 3. P. 701 -787 | 171 | 25% | 5 |
8 | DRUMMOND, DC , NOBLE, CO , HAYES, ME , PARK, JW , KIRPOTIN, DB , (2008) PHARMACOKINETICS AND IN VIVO DRUG RELEASE RATES IN LIPOSOMAL NANOCARRIER DEVELOPMENT.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 97. ISSUE 11. P. 4696-4740 | 121 | 42% | 119 |
9 | OKU, N , NAMBA, Y , (1994) LONG-CIRCULATING LIPOSOMES.CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS. VOL. 11. ISSUE 4. P. 231-270 | 106 | 82% | 78 |
10 | GUBERNATOR, J , (2011) ACTIVE METHODS OF DRUG LOADING INTO LIPOSOMES: RECENT STRATEGIES FOR STABLE DRUG ENTRAPMENT AND INCREASED IN VIVO ACTIVITY.EXPERT OPINION ON DRUG DELIVERY. VOL. 8. ISSUE 5. P. 565 -580 | 66 | 72% | 39 |
Classes with closest relation at Level 1 |